Related Experiment Video
Updated: May 21, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs as therapeutic targets and their potential applications in cancer therapy
1Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13/F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong. chocs@ha.org.hk
Introduction:
The results of cancer-associated miRNA research have yielded surprising insights into the pathogenesis of a range of different cancers. Many of the dysregulated miRNAs are involved in the regulation of genes that are essential for carcinogenesis.
Areas Covered:
This review discusses the latest discovery of miRNAs acting as oncogenes and tumor suppressor genes, as well as the potential applications of miRNA regulations in cancer therapy. Several translational studies have demonstrated the feasibility of targeting oncogenic miRNAs and restoring tumor-suppressive miRNAs for cancer therapy using in vivo model systems.
Expert Opinion:
miRNAs are extensive regulators of cancer progression. With increasing understanding of the miRNA target genes and the cellular behaviors influenced by them, modulating the miRNA activities may provide exciting opportunities for cancer therapy. Despite the hurdles incurred in acquiring effective systemic drug delivery systems, in vivo delivery of miRNAs for therapeutic purposes in preclinical animal models is rapidly developing. Accumulating evidences indicate that using miRNA expression alterations to influence molecular pathways has the potential of being translated into clinical applications.
Insights
MicroRNAs (miRNAs) are key regulators in cancer development. Research shows targeting these molecules offers promising new avenues for effective cancer therapies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNA (miRNA) research reveals critical roles in cancer pathogenesis.
- Dysregulated miRNAs are implicated in the regulation of key carcinogenesis genes.
Purpose of the Study:
- To review the latest discoveries of miRNAs as oncogenes and tumor suppressors.
- To explore the therapeutic potential of miRNA regulation in cancer treatment.
Main Methods:
- Literature review of recent miRNA research and translational studies.
- Analysis of in vivo model systems for miRNA-based cancer therapy.
Main Results:
- miRNAs function as both oncogenes and tumor suppressors in various cancers.
- Translational studies confirm the feasibility of targeting miRNAs in preclinical models.
Conclusions:
- miRNAs significantly regulate cancer progression.
- Modulating miRNA activity presents novel therapeutic opportunities for cancer.
- In vivo delivery of miRNAs for therapy is advancing rapidly, showing clinical potential.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics

